Clinical Trial

EWALL-PH OBSERVARTORY 2022

Name: EWALL-PH OBSERVARTORY 2022 — clinical trial record (NCT07684131)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Ewall Obs 2022

Recruiting

View on ClinicalTrials.gov →

Summary

An observatory for patients aged 18 years and over with Philadelphia chromosome positive (Ph+ or BCR::ABL1) acute lymphoblastic leukemia (ALL) and treated with the combination of BCR::ABL1 inhibitors and chemotherapy and/or corticosteroids and/or a monoclonal antibody.

Trial Details

NCT Number	NCT07684131
Lead Sponsor	Versailles Hospital
Conditions	Acute Lymphoblastic Leukemia
Enrollment	100 participants
Start Date	2024-01-15
Primary Completion	2027-06-15 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-06